Stoke Therapeutics, Inc. (STOK) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $444K. Most recent filing: Aug. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 18, 2026 filed Aug. 14, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | — | +5,233 | +26% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 14, 2026 | Kaye Edward M. MD Director | — | +13,683 | +12% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 14, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | — | +3,139 | +17% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | −$208,385 | 7,176 | −26% | Yes | |
|
|
||||||
| July 17, 2026 filed July 16, 2026 | Harrison Seth Loring Director | $0 | 303,190 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free